Risk factors for motor response complications in L-dopa-treated parkinsonian patients

Adv Neurol. 1993;60:698-702.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Carbidopa / adverse effects*
  • Carbidopa / therapeutic use
  • Drug Combinations
  • Dyskinesia, Drug-Induced / etiology
  • Female
  • Follow-Up Studies
  • Humans
  • Levodopa / adverse effects*
  • Levodopa / therapeutic use
  • Long-Term Care
  • Male
  • Middle Aged
  • Motor Activity / drug effects*
  • Neurologic Examination / drug effects*
  • Parkinson Disease / drug therapy*
  • Risk Factors

Substances

  • Antiparkinson Agents
  • Drug Combinations
  • carbidopa, levodopa drug combination
  • Levodopa
  • Carbidopa